Croda International (LON:CRDA) Insider Steve Foots Buys 5 Shares of Company Stock

Key Points

• Insider buying: Croda International director Steve Foots purchased 5 shares at GBX 3,388 each, investing £169.40; he also bought 5 shares in August.
• Stock performance: Shares rose to GBX 3,517, near the 52-week high of GBX 3,543, with a market capitalization of approximately £4.90 billion and a P/E ratio of 61.81.
• Analyst outlook: Croda has a consensus “Moderate Buy” rating from analysts, with an average price target of GBX 3,490; forecasts call for full-year EPS of GBX 181.83.

Croda International Plc (LON:CRDA - Get Free Report) insider Steve Foots acquired 5 shares of the stock in a transaction on Monday, October 12th. The stock was bought at an average price of GBX 3,388 per share, for a total transaction of £169.40.

Steve Foots also recently made the following trade(s):

• On Monday, August 10th, Steve Foots acquired 5 shares of Croda International stock. The shares were purchased at an average cost of GBX 3,292 per share, for a total transaction of £164.60.

Croda International Stock Performance

Shares of LON:CRDA traded up GBX 100 during trading on Tuesday, hitting GBX 3,517. 463,121 shares of the stock traded hands, compared to its average volume of 4,424,601. The company has a quick ratio of 2.25, a current ratio of 2.57 and a debt-to-equity ratio of 36.06. The company has a market cap of £4.90 billion, a price-to-earnings ratio of 61.81, a P/E/G ratio of 1.40 and a beta of 0.92. The company has a fifty day moving average price of GBX 3,295.78 and a two-hundred day moving average price of GBX 3,075.73. Croda International Plc has a 52-week low of GBX 2,488 and a 52-week high of GBX 3,543.

Croda International (LON:CRDA - Get Free Report) last posted its earnings results on Tuesday, July 28th. The company reported GBX 72.20 earnings per share (EPS) for the quarter. Croda International had a net margin of 4.61% and a return on equity of 3.65%. As a group, equities analysts predict that Croda International Plc will post 181.83 EPS for the current year.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on CRDA. Jefferies Financial Group reiterated a "buy" rating and issued a GBX 4,000 price objective on shares of Croda International in a research report on Friday, September 25th. Deutsche Bank Aktiengesellschaft restated a "hold" rating and set a GBX 3,300 target price on shares of Croda International in a research report on Wednesday, July 29th. Berenberg Bank restated a "buy" rating and issued a GBX 3,600 price target on shares of Croda International in a research note on Wednesday, July 29th. Finally, Citigroup upped their price target on Croda International from GBX 3,050 to GBX 3,200 and gave the stock a "neutral" rating in a report on Wednesday, July 29th. Three analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of GBX 3,490.

Croda International Company Profile

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.